Jeroen Tjaden

Jeroen specializes in corporate law and private M&A, with a particular focus on private equity on both the sell-side and the buy-side and restructuring.

Image
Jeroen Tjaden Stibbe

Jeroen Tjaden

Senior Associate Amsterdam

Jeroen specializes in corporate law and private M&A, with a particular focus on private equity on both the sell-side and the buy-side and restructuring.

Jeroen Tjaden

Senior Associate Amsterdam

Jeroen’s work highlights include being lead-associate in various buy-side and sell-side private equity transactions, restructurings and carve-outs often involving multiple jurisdictions. He worked in our Brussels office in 2019 and in our London office from 2020 to 2022.

He holds a master’s degree in private law and corporate law from the VU University in Amsterdam (cum laude; 2015)

Languages: Dutch, English
Admitted to the Amsterdam Bar: 2016
Office building
Matter
NL Law

Stibbe advised Shinagawa Refractories on the acquisition of Gouda Refractories Group

Stibbe has successfully advised Shinagawa Refractories Co., Ltd (“Shinagawa”) on the acquisition of all issued share capital of Gouda Refractories Group B.V. (“Gouda”).

Continue reading
Skyline of the Zuidas
Matter
NL Law

Stibbe advises Schneider Electric Industries SAS

Stibbe has advised Schneider Electric Industries SAS, the market leader in the digital transformation of energy management and automation, on its successful expansion of its investment in Planon Beheer B.V.

Continue reading
Office building sun flare
Matter
NL Law

Stibbe advises Q-Park on sale of stake to Interogo Holding AG

Stibbe has advised Q-Park, a leading European owner and operator of parking infrastructure, on the sale of a 12.25% stake to Interogo Holding AG’s infrastructure investment fund, Inter Infrastructure Capital.

Continue reading
Cropped close-up of a pharmacy's green cross sign
Matter
NL Law
EU Law

Stibbe advises Medios AG

Stibbe advises Medios on its acquisition of Ceban for around EUR 260 mio. Medios is a German pharmaceutical company listed on the Frankfurt stock exchange. Dutch Ceban prepares medicines for hospitals and pharmacies, also known as compounding.

Continue reading